| Retrovir Official FDA information, side effects and uses. Accurate, FDA approved Retrovir information for healthcare professionals and patients - brought to you by Drugs.com. Read More |
| Zidovudine - Wikipedia, the free encyclopedia Zidovudine (INN) or azidothymidine (AZT) (also called ZDV) is a nucleoside analog reverse-transcriptase inhibitor (NRTI), a type of antiretroviral drug used for the ... Read More |
| Retrovir (Zidovudine) Drug Information: Description, User Reviews ... Learn about the prescription medication Retrovir (Zidovudine), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| AIDSmeds.com - Retrovir Complete info about Retrovir (zidovudine, AZT), a nucleoside analogue Read More |
| Retrovir (Zidovudine, AZT) - HOME | hivandhepatitis.com Articles on Retrovir Structural Basis for HIV-1 Reverse Transcriptase Drug Resistance to Zidovudine (AZT) ... Read More |
| Retrovir Facts and Comparisons at Drugs.com All about Retrovir. View complete and up to date Retrovir information - part of the Drugs.com trusted medication database. Read More |
| Retrovir - Side Effects, Dosage, Interactions - Drugs ... What is Retrovir (Zidovudine)? Zidovudine (Oral) Zidovudine is an antiviral medication that prevents human immunodeficiency virus (HIV) cells from multiplying in your ... Read More |
| Retrovir - drugstore.com. Low prices, side effects, interactions. Retrovir is an antiviral used to treat human immunodeficiency virus infection (HIV) when used along with other medicines. Side effects and interactions are available ... Read More |
| Retrovir - AIDS Home Page Retrovir is approved for the treatment of HIV infection and AIDS. This eMedTV Web page describes the effects of the drug in detail, explains what you should know ... Read More |
| RETROVIRĀ®(zidovudine) TabletsRETROVIRĀ®(zidovudine ... warning. retrovir (zidovudine) has been associated with hematologic toxicity including neutropenia and severe anemia particularly in patients with advanced human ... Read More |